This webinar gives the Indian perspective on the JNC 8 blood pressure guidelines’ recommendations.
Description of the Webinar
The appropriate control of blood pressure results in reduced progression of chronic kidney disease (CKD) and the incidence of end stage renal disease (ESRD). The JNC 8 recommends higher blood pressure threshold for initiation of anti-hypertensive therapy, higher BP targets, and separate and higher values for those above age 60. Additionally, it also fails to suggest separate lower targets for proteinuric CKD patients. If implemented, these recommendations would result in fewer patients being treated, and with lesser “intensity”. How would this impact the incidence of ESRD? Adverse outcomes if any, would only be apparent in the distant future. It is feared that the developing economies like India will have already bourn the increased burden of ESRD by then! A balanced audit of JNC 8 recommendations and the large number of dissenting ‘counter points’ arising from them is urgently called for.
The session webcasts
JNC 8 Recommendations – an Indian perspective
This webinar was held on Tuesday September 16th, 2014, from 8:30 – 9:30 AM EDT (Eastern Daylight Time).
About the Facilitators
Ashok L. Kirpalani is currently Professor and Head of Department of Nephrology at the Bombay Hospital Institute of Medical Sciences, Mumbai, India. He has played a key role in promoting and advancing the field of nephrology in India. He has been a dedicated post-graduate teacher for the last 37 years. He is the current President of the Indian Society of Organ Transplantation and has served as the President of the Indian Society of Nephrology in 2004. In 2005 he founded and established the CKD Registry of India and was the Convener and Editor of the first Indian CKD Guidelines published by the Indian Society of Nephrology. He has more than 100 scientific presentations and publications to his credit.